Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 52 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Loutradis, Charalampos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Alexandrou, M. Eleni, Loutradis C., Schoina M., Tzanis G., Dimitriadis C., Sachpekidis V., et al. (2020).  Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients.. Hypertens Res. 43(9), 903-913.
Schoina, M., Loutradis C., Minopoulou I., Theodorakopoulou M., Pyrgidis N., Tzanis G., et al. (2020).  Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease.. Am J Nephrol. 51(5), 411-420.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2019).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 34(3), 515-523.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2020).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 35(7), 1277.
B
Loutradis, C., Papadopoulou E., Angeloudi E., Karagiannis A., & Sarafidis P. (2020).  The Beneficial Hemodynamic Actions of SGLT-2 Inhibitors beyond the Management of Hyperglycemia.. Curr Med Chem. 27(39), 6682-6702.
Sarafidis, P., Loutradis C., Ortiz A., & Ruilope L. M. (2020).  Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.. Clin Kidney J. 13(3), 287-290.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Karpetas, A., Loutradis C., Bikos A., Tzanis G., Koutroumpas G., Lazaridis A. A., et al. (2017).  Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients.. J Hypertens. 35(12), 2517-2526.
C
Alexandrou, M-E., Loutradis C., Balafa O., Theodorakopoulou M., Tzanis G., Bakaloudi D., et al. (2020).  A comparative study of ambulatory central hemodynamics and arterial stiffness parameters in peritoneal dialysis and hemodialysis patients.. J Hypertens. 38(12), 2393-2403.
Bikos, A., Angeloudi E., Memmos E., Loutradis C., Karpetas A., Ginikopoulou E., et al. (2018).  A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.. Am J Nephrol. 48(4), 295-305.
Loutradis, C., Schoina M., Dimitroulas T., Doumas M., Garyfallos A., Karagiannis A., et al. (2020).  Comparison of ambulatory central hemodynamics and arterial stiffness in patients with diabetic and non-diabetic CKD.. J Clin Hypertens (Greenwich).
D
Papadopoulou, E., Loutradis C., Tzatzagou G., Kotsa K., Zografou I., Minopoulou I., et al. (2020).  Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.. J Hypertens.
Papadopoulou, E., Theodorakopoulou M. P., Loutradis C., Tzanis G., Tzatzagou G., Kotsa K., et al. (2021).  Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.. Am J Hypertens. 34(4), 404-413.
Moschopoulou, M., Ampatzidou F. Ch, Loutradis C., Boutou A., Koutsogiannidis C-P., Drosos G. E., et al. (2016).  Diabetes mellitus does not affect the incidence of acute kidney injury after cardiac surgery; a nested case-control study.. J Nephrol. 29(6), 835-845.
Loutradis, C., Skodra A., Georgianos P., Tolika P., Alexandrou D., Avdelidou A., et al. (2016).  Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.. World J Nephrol. 5(4), 358-66.
E
Loutradis, C., Sarafidis P. A., Papadopoulos C. E., Papagianni A., & Zoccali C. (2018).  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.. J Am Soc Nephrol. 29(5), 1372-1381.
Tsilonis, K., Sarafidis P. A., Kamperidis V., Loutradis C., Georgianos P. I., Imprialos K., et al. (2016).  Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients.. Am J Kidney Dis. 68(5), 772-781.
Loutradis, C., Sarafidis P. A., Ekart R., Papadopoulos C., Sachpekidis V., Alexandrou M. Eleni, et al. (2019).  The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.. Kidney Int. 95(6), 1505-1513.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus. Journal of Hypertension. 1.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection. Future Medicinal Chemistry. 2019 Jun;11(11):1285-1303.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Theodorakopoulou, M., Loutradis C., Bikos A., Angeloudi E., Schoina M., Raptis V., et al. (2020).  The Effects of Nebivolol and Irbesartan on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Hemodialysis Patients with Intradialytic Hypertension.. Blood Purif. 1-11.
Bikos, A., Loutradis C., Angeloudi E., Karpetas A., Raptis V., Kalaitzidis R., et al. (2019).  The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.. J Hypertens. 37(2), 432-442.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές